DRTECH Corporation

KOSDAQ:A214680 Stock Report

Market Cap: ₩188.0b

DRTECH Past Earnings Performance

Past criteria checks 0/6

DRTECH's earnings have been declining at an average annual rate of -14.4%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 15.6% per year.

Key information

-14.4%

Earnings growth rate

-8.9%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate15.6%
Return on equity-16.8%
Net Margin-15.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

DRTECH Corporation's (KOSDAQ:214680) Popularity With Investors Is Under Threat From Overpricing

Oct 31
DRTECH Corporation's (KOSDAQ:214680) Popularity With Investors Is Under Threat From Overpricing

DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

Sep 11
DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

DRTECH Corporation's (KOSDAQ:214680) 28% Price Boost Is Out Of Tune With Revenues

Jul 17
DRTECH Corporation's (KOSDAQ:214680) 28% Price Boost Is Out Of Tune With Revenues

What DRTECH Corporation's (KOSDAQ:214680) 34% Share Price Gain Is Not Telling You

May 08
What DRTECH Corporation's (KOSDAQ:214680) 34% Share Price Gain Is Not Telling You

DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

Apr 29
DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

We Think DRTECH (KOSDAQ:214680) Has A Fair Chunk Of Debt

Apr 14
We Think DRTECH (KOSDAQ:214680) Has A Fair Chunk Of Debt

Reflecting on DRTECH's (KOSDAQ:214680) Share Price Returns Over The Last Three Years

Feb 17
Reflecting on DRTECH's (KOSDAQ:214680) Share Price Returns Over The Last Three Years

DRTECH (KOSDAQ:214680) Is Making Moderate Use Of Debt

Dec 22
DRTECH (KOSDAQ:214680) Is Making Moderate Use Of Debt

Revenue & Expenses Breakdown

How DRTECH makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A214680 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2489,823-13,90627,98513,179
31 Mar 2486,598-8,56728,36712,361
31 Dec 2392,439-2,24827,55111,517
30 Sep 2393,339-1,65427,28510,197
30 Jun 2394,1472,33226,9929,981
31 Mar 2394,4986,61223,89810,740
31 Dec 2289,4815,96421,88010,819
30 Sep 2281,4287,25521,55110,915
30 Jun 2275,6275,03018,99010,973
31 Mar 2273,0154,75019,96411,042
31 Dec 2170,2774,03817,97611,016
30 Sep 2169,76194817,56410,687
30 Jun 2164,884-2,07216,90810,295
31 Mar 2158,726-6,97315,0389,894
31 Dec 2055,268-7,23015,7539,236
30 Sep 2054,409-1,61113,7118,674
30 Jun 2052,574113,3448,304
31 Mar 2049,7211,28512,3477,688
31 Dec 1947,84594511,9937,171
30 Sep 1946,8671,19411,6947,064
30 Jun 1946,64182111,8476,831
31 Mar 1945,8301,20312,1986,316
31 Dec 1844,7141,24611,6946,131
30 Sep 1841,883-52311,0105,405
30 Jun 1839,816-1,53611,0865,301
31 Mar 1839,785-1,55411,2875,077
31 Dec 1738,804-1,81510,9335,378
30 Sep 1739,003-71710,4915,213
30 Jun 1737,232-1,76810,0975,349
31 Mar 1738,336-1009,2105,621
31 Dec 1636,639-4359,6894,808

Quality Earnings: A214680 is currently unprofitable.

Growing Profit Margin: A214680 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A214680 is unprofitable, and losses have increased over the past 5 years at a rate of 14.4% per year.

Accelerating Growth: Unable to compare A214680's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A214680 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.6%).


Return on Equity

High ROE: A214680 has a negative Return on Equity (-16.81%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies